CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.252
NA - Nord America 2.697
AS - Asia 2.186
SA - Sud America 311
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.644
RU - Federazione Russa 1.509
SG - Singapore 906
CN - Cina 743
GB - Regno Unito 497
BR - Brasile 246
IT - Italia 242
DE - Germania 220
HK - Hong Kong 212
FR - Francia 196
IE - Irlanda 185
SE - Svezia 168
VN - Vietnam 116
FI - Finlandia 80
KR - Corea 58
UA - Ucraina 42
JP - Giappone 39
AR - Argentina 28
CA - Canada 28
IN - India 27
NL - Olanda 27
MX - Messico 19
PL - Polonia 16
BD - Bangladesh 15
BE - Belgio 15
ID - Indonesia 15
TR - Turchia 12
ES - Italia 11
TG - Togo 11
ZA - Sudafrica 11
DZ - Algeria 10
BJ - Benin 8
EC - Ecuador 8
AT - Austria 7
CO - Colombia 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
MA - Marocco 6
CL - Cile 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
NO - Norvegia 3
PT - Portogallo 3
UG - Uganda 3
VE - Venezuela 3
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
WS - Samoa 1
Totale 8.514
Salva come PNG Salva come JPEG
Città #
Moscow 515
Southend 438
Chandler 418
Singapore 402
Dallas 333
Ashburn 256
Hong Kong 207
Dublin 181
Beijing 172
Jacksonville 153
Woodbridge 111
Verona 94
The Dalles 76
Munich 73
Lawrence 65
Princeton 65
Houston 58
Los Angeles 57
Jinan 55
New York 50
Redmond 49
Wilmington 45
Nanjing 43
Ho Chi Minh City 39
Shenyang 39
Helsinki 38
Redondo Beach 34
São Paulo 31
Tokyo 30
Tianjin 29
Columbus 28
Hanoi 28
Buffalo 26
Ann Arbor 24
Haikou 24
Santa Clara 24
Redwood City 23
Hangzhou 21
Changsha 19
Hebei 19
Ningbo 19
Sindelfingen 19
Nanchang 18
Seattle 18
Turku 18
Falkenstein 16
Atlanta 15
Brussels 15
London 14
Washington 14
Brooklyn 13
Denver 13
Milan 13
Montreal 13
Nuremberg 13
Warsaw 13
Zhengzhou 13
Fairfield 12
Orem 12
Rio de Janeiro 12
Frankfurt am Main 11
Lomé 11
Norwalk 11
Taiyuan 11
Taizhou 11
Amsterdam 10
Chicago 10
Belo Horizonte 9
Council Bluffs 9
Fuzhou 9
Lancaster 9
Lappeenranta 9
San Francisco 9
Stockholm 9
Chennai 8
Cotonou 8
Falls Church 8
Genoa 8
Jakarta 8
Johannesburg 8
Mexico City 8
Toronto 8
Mumbai 7
Poplar 7
Ankara 6
Boston 6
Curitiba 6
Dongguan 6
Guangzhou 6
Haiphong 6
Hyderabad 6
Jiaxing 6
Pignone 6
Algiers 5
Düsseldorf 5
Kent 5
Manchester 5
Meda 5
Ottawa 5
Phoenix 5
Totale 4.990
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 206
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 202
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 186
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 185
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 182
Results of a surveillance protocol for pancreatic BD-IPMNs 168
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 164
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 158
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 158
An unforeseeable adverse event during ERCP 153
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 153
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 149
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 148
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 145
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 144
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 140
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 139
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 136
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 135
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 133
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 131
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 131
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 129
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 128
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 125
Pancreatic Adenocarcinoma 125
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 125
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 125
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 124
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 123
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 122
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 117
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 116
Defining the practice of distal pancreatectomy around the world 116
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 116
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 115
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 112
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 111
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 111
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 110
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 110
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 108
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 108
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 107
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 99
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 96
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 94
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 92
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 90
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 90
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 85
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 85
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 83
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 82
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 81
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 80
Intraductal Papillary Mucinous Neoplasm Around the World 77
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 77
Response to: Managing the High-risk Pancreatic Anastomosis 75
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 75
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 74
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 74
Surgical experience and the practice of pancreatoduodenectomy 71
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 70
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 70
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 69
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 67
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 67
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 67
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 66
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 65
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 63
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 62
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 59
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 59
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 57
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 54
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 52
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 48
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 45
Totale 8.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.994
article - articoli 31.927
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 670
patent - brevetti 0
selected - selezionate 0
volume - volumi 397
Totale 65.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 83 29 5 13 16 44 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20263.214 365 218 343 742 1.304 242 0 0 0 0 0 0
Totale 8.649